Disease/Infection News

RSS

Dalbavancin surveillance antibiotic results for Gram-positive pathogens presented at ECCMID meeting

Durata Therapeutics today announced surveillance data demonstrating potency of the Company's lead antibiotic product, dalbavancin, a long-acting, intravenous lipoglycopeptide, against a broad spectrum of gram-positive bacteria prevalent in recent years.

10 May 2011

HIV drugs can be used to target malaria and other parasitic diseases

Drugs used to treat HIV may form templates for lifesaving drugs targeted at malaria and other parasitic diseases, according to a new study from Cardiff University.

10 May 2011

First study to look at birth-cohort screening outcomes for hepatitis C virus

New research indicates that screening people born between 1946 and 1970 for hepatitis C virus instead of current risk-based screening practices is cost effective and could lead to 106,000 fewer cases of advanced liver disease and 59,000 fewer HCV-related deaths. An estimated 1.6 million U.S. residents ages 40 to 64 are infected with HCV but do not know it.

10 May 2011

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

The Laboratory Department for Probiotics Research at the Juntendo University Graduate School of Medicine studied supplementation of probiotic fermented milk containing Lactobacillus casei strain Shirota in elderly individuals living at a nursing home and confirmed reduced fever associated with acute norovirus gastroenteritis.

10 May 2011

Merck launches 'Hope Against Hepatitis C' education program

Merck, known as MSD outside the United States and Canada, today announced the launch of Hope Against Hepatitis C, a company initiative to increase awareness, prevention and diagnosis of hepatitis C virus infection.

10 May 2011

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results of several studies designed to support the continued advancement of its lead antibiotic, TP-434, a potent new broad-spectrum intravenous antibiotic with oral stepdown potential effective against difficult-to-treat and multidrug-resistant pathogens.

10 May 2011

More than half of all adolescents accept free rapid HIV test after risk assessment survey

Although the Centers for Disease Control and Prevention recommends routine HIV testing for everyone between the ages of 13-64 as part of their regular medical care, testing rates remain low among adolescents.

10 May 2011

Pheromone-based traps for monitoring and catching bed bugs

In the worldwide race to develop a solution, SpringStar Inc, a Seattle-area biotech company, is releasing two new advanced pheromone-based traps for monitoring and catching bed bugs.

10 May 2011

Pfizer presents SA3Ag staphylococcal vaccine Phase 1 trial data at ECCMID/ICC

Inhibitex, Inc., announced today that Pfizer Inc. presented safety and immunogenicity data from a Phase 1 double-blind randomized placebo controlled study in 408 healthy volunteers of a novel three antigen Staphylococcus aureus investigational vaccine at the 21st European Congress of Clinical Microbiology and Infectious Diseases and 27th International Congress of Chemotherapy in Milan, Italy.

10 May 2011

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

For infants and young children with urinary tract infection seen in the ER, a simple ultrasound examination may avoid the need for more complex x-ray tests, reports a study in the May issue of The Pediatric Infectious Disease Journal.

10 May 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Aethlon Medical, Inc. announces that it has submitted a request to the U.S. Food and Drug Administration for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier in the United States.

10 May 2011

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

"Cracking the Safe: Advances in HIV/AIDS Prevention and Treatment" is a one-day symposium at the New York Academy of Sciences examining issues facing researchers working towards the development of an HIV/AIDS vaccine, including updates on current challenges and solutions.

10 May 2011

U.S. boosts Cote d'Ivoire commitment; polio vaccine campaign delayed in country's southern region

The U.S. has pledged an additional $8.5 million to relief efforts in Cote d'Ivoire after post-election violence led to hundreds of thousands of internally displaced people and refugees, Devex reports.

10 May 2011

Starpharma inks licence agreement in Japan with Okamoto for VivaGel-coated condoms

Starpharma Holdings Limited today announced that it has signed a licence agreement with Okamoto Industries Inc in relation to the VivaGel(r)-coated condom for the Japanese market. Okamoto is the market leader for condoms sold in Japan, the world's second largest condom market.

10 May 2011

Opinions: Democracy needed in epidemic outbreaks; U.S. food aid; development partnerships in Africa

After mentioning the riots that broke out in Haiti after the start of the cholera epidemic last year, Richard Evans, a professor of history and president of Wolfson College at the University of Cambridge, writes in a Guardian opinion piece that "popular disturbances during epidemics are nothing new." He goes on to provide several other examples.

10 May 2011

Uganda: First vaccination for GMZ2 malaria vaccine trial

Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the third trial site to initiate volunteer recruitment for this multi-country study. Vaccination is already underway at trial sites in Gabon (November 2010) and Burkina Faso (April 2011). The Uganda site is in the peri-urban area of Iganga/Mayuge, at the Iganga Hospital. Akin to most areas in Uganda, malaria is one of the major health problems in this district. A team from Makerere University (Kampala) is conducting the trial.

9 May 2011

World's first urine-based tuberculosis diagnostics tool

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the world's first urine-based tuberculosis diagnostics tool.

9 May 2011

New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

A real-world study evaluating the safety of GARDASIL among 189,629 females in California found no serious adverse events related to vaccination, no safety signals for any health event resulting in an emergency room visit or hospitalization and no safety signals associated with pre-specified autoimmune conditions or pregnancy outcomes.

9 May 2011

Innovative detection practices may prevent liver diseases

Research being presented at Digestive Disease Week- shows that screening individuals for hepatitis C based on age instead of conventional risk factors may help increase detection rates as well as prevent liver disease.

9 May 2011

Parasites in human waste fertilizers alarm health experts

It has been suggested that human faeces used as fertiliser on farms are leading to the spread of ‘Third World’ parasites causing a serious stomach illness across Sydney.

8 May 2011

Disease/Infection News

Dalbavancin surveillance antibiotic results for Gram-positive pathogens presented at ECCMID meeting

HIV drugs can be used to target malaria and other parasitic diseases

First study to look at birth-cohort screening outcomes for hepatitis C virus

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

Merck launches 'Hope Against Hepatitis C' education program

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

More than half of all adolescents accept free rapid HIV test after risk assessment survey

Pheromone-based traps for monitoring and catching bed bugs

Pfizer presents SA3Ag staphylococcal vaccine Phase 1 trial data at ECCMID/ICC

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

U.S. boosts Cote d'Ivoire commitment; polio vaccine campaign delayed in country's southern region

Starpharma inks licence agreement in Japan with Okamoto for VivaGel-coated condoms

Opinions: Democracy needed in epidemic outbreaks; U.S. food aid; development partnerships in Africa

Uganda: First vaccination for GMZ2 malaria vaccine trial

World's first urine-based tuberculosis diagnostics tool

New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

Innovative detection practices may prevent liver diseases

Parasites in human waste fertilizers alarm health experts

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News